Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
CA 2485709 A1 · Owner: Martin, Donald Keith · Inventors: Martin, Donald Keith; Markhotina, Natalya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for determining or identifying compounds that modulate the function of an isolated retinal pericyte or blood vessel , wherein a change in the contractile state of said pericyte or blood vessel is determined in the presence of a test compound said change , indicating that the test compound modulates the function of pericytes and/or blood vessels.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.